Journal home
Advance online publication
Current issue
Archive
Press releases
Free Association (blog)
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Biotechnology
Nature Cell Biology
Nature Medicine
Nature Methods
Nature Reviews Cancer
Nature Reviews Genetics
Nature Reviews Molecular Cell Biology
news@nature.com
Nature Conferences
Nature Reports Stem Cells
RNAi Gateway
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Genetics  36, 233 - 239 (2004)
Published online: 8 February 2004; | doi:10.1038/ng1311

The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke

Anna Helgadottir1, Andrei Manolescu1, Gudmar Thorleifsson1, Solveig Gretarsdottir1, Helga Jonsdottir1, Unnur Thorsteinsdottir1, Nilesh J Samani2, Gudmundur Gudmundsson1, Struan F A Grant1, Gudmundur Thorgeirsson3, Sigurlaug Sveinbjornsdottir3, Einar M Valdimarsson3, Stefan E Matthiasson3, Halldor Johannsson3, Olof Gudmundsdottir1, Mark E Gurney1, Jesus Sainz1, Margret Thorhallsdottir1, Margret Andresdottir1, Michael L Frigge1, Eric J Topol4, Augustine Kong1, Vilmundur Gudnason5, Hakon Hakonarson1, Jeffrey R Gulcher1 & Kari Stefansson1

1  deCODE genetics, Sturlugata 8, Reykjavik, Iceland.

2  Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, UK.

3  National University Hospital, Reykjavik, Iceland.

4  Cleveland Clinic Foundation, Cleveland, Ohio, USA.

5  Icelandic Heart Association, Reykjavik, Iceland.

Correspondence should be addressed to Kari Stefansson kstefans@decode.is
We mapped a gene predisposing to myocardial infarction to a locus on chromosome 13q12−13. A four-marker single-nucleotide polymorphism (SNP) haplotype in this locus spanning the gene ALOX5AP encoding 5-lipoxygenase activating protein (FLAP) is associated with a two times greater risk of myocardial infarction in Iceland. This haplotype also confers almost two times greater risk of stroke. Another ALOX5AP haplotype is associated with myocardial infarction in individuals from the UK. Stimulated neutrophils from individuals with myocardial infarction produce more leukotriene B4, a key product in the 5-lipoxygenase pathway, than do neutrophils from controls, and this difference is largely attributed to cells from males who carry the at-risk haplotype. We conclude that variants of ALOX5AP are involved in the pathogenesis of both myocardial infarction and stroke by increasing leukotriene production and inflammation in the arterial wall.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Wanted: regulatory SNPs

Nature Genetics News and Views (01 Apr 2003)

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend

Open Innovation Challenges

naturejobs

Competing financial interests
Figures & Tables
Supplementary info
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Genetics
ISSN: 1061-4036
EISSN: 1546-1718
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2004 Nature Publishing Group | Privacy policy